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Summary: The significance of the two most common hallmarks of the diabetic state, hyperglycaemia and
hyperlipidaemia, was investigated in terms of disorders of cell membrane dynamics. In order to examine
whether the alterations in cell membrane lipid bilayer dynamics are somehow related to protein chemical
modifications in plasma low- (LDL) and high-density lipoproteins (HDL) and blood cell membranes, we
compared 19 poorly controlled diabetic subjects with 19 age- and sex-matched controls. The extent of (non-
enzymatic) glycation, lipid peroxidation and the cholesterol/phospholipid ratio were increased in plasma low
density lipoproteins and high density lipoproteins from diabetic patients. The mean steady-state fluorescence
polarization values in l,6-diphenyl-l,3,5-hexatriene-labelled isolated erythrocyte membranes from diabetic
subjects were significantly greater than from control subjects (0.186 ± 0.008 vs 0.173 ± 0.006, p < 0.001);
the fluorescence polarization values in erythrocyte membranes from diabetic and control subjects positively
correlated with the extent of membrane protein glycation, lipid peroxidation and the cholesterol content. The
cholesterol to phospholipid molar ratios in low density lipoproteins and high-density lipoproteins from diabetic
and control subjects correlated significantly with the fluorescence polarization values in erythrocyte membranes
from these subjects. Furthermore, the extent of glycation of low density lipoproteins appears to be strongly
correlated with the extent of lipoprotein lipid peroxidation (r = 0.789, p < 0.001).
The atherosclerotic potential of plasma lipoproteins in diabetes mellitus was discussed in terms of membrane
and plasma protein chemical modifications.
Introduction . , . Λ Λ ,. ,acid content, might occur, leading to alterations in
Elevated plasma cholesterol concentrations and dis- membrane lipids and enzyme activities (4). Changes
turbed lipid metabolism are major risk factors in the in erythrocyte membrane lipids and fluidity appear
pathogenesis of atherosclerosis and its thromboem- to be major determinants in erythrocyte elasticity and
bolic complications in both the diabetic and non- deformability (5). However, the relation between
diabetic populations (1). The concept that altered low membrane-associated alterations and the formation
density lipoproteins may have a role in the pathogen- of atherosclerotic lesions remains unclear. There is
esis of atherosclerosis has emerged as a consequence increasing evidence which indicates that non-enzy-
of recent advances in our understanding of the mech- matic glycation of various proteins is an important
anism involved in the interactions of lipoproteins with molecular event in the diabetic state (6). There is also
cells (2, 3). As a result of these interactions, a rapid evidence to support the idea that many of the corn-
change in cell membrane composition, particularly plications of diabetes result from hyperglycaemia (7).
with regard to cholesterol, phospholipid, and fatty The observation that post-translational non-enzy-
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matic glycation of proteins can occur under physio-
logical conditions has indicated that this could be at
least one mechanism through which hyperglycaemia
could lead to alterations in protein structure (8, 9).
Increased non-enzymatic glycation of plasma lipopro-
teins has been implicated in the aetiology of several
complications in diabetes mellitus, including vascular
disease (2, 10, 11). Other chemically or biologically
modified low density lipoproteins are also poorly rec-
ognized by the low density lipoprotein receptor (11).
Recently, there has been increased interest in the idea
that low density lipoproteins modified by oxidation
may contribute to some of the changes associated
with the formation of the atherosclerotic plaque. Sev-
eral of the functional changes reported to occur when
low density lipoproteins become oxidized indicate a
possible role for oxidized low density lipoproteins in
various pathological conditions (10, 11). The non-
enzymatic glycation was correlated with the impaired
dynamic properties of erythrocyte and platelet mem-
branes from diabetic subjects (12, 13). Although their
increased non-enzymatic glycation in diabetes is well
recognized (7, 9, 10, 12, 13), the evidence that oxi-
dation is also increased and accompanies the process
of protein glycation has not been so far unambigu-
ously proven in diabetic subjects.
In the present study, we determined the influence of
diabetes on erythrocyte membrane fluidity and on the
cholesterol to phospholipid molar ratio in erythrocyte
membranes and in plasma lipoproteins. We also com-
pared the extent of non-enzymatic glycation and ac-
cumulation of lipid peroxidation products in eryth-
rocyte membranes and apoproteins of low density
lipoproteins and high density lipoproteins in diabetic
and control subjects, in order to determine the influ-
ence of possible chemical modifications of proteins
on red blood cell membrane dynamics.
Materials and Methods
Subjects
Nineteen non-fasting diabetic patients (13 men: 11 type I in-
sulin-dependent, 2 type II non-insulin-dependent; 6 women: 5
type 1,1 type II with a mean ± SD age of 36 ± 10 years (range
23-53) and 19 age- (36 ± 10 years, range 22-57) and sex-
matched control subjects were studied. Mean body weights were
not significantly different between control (70.7 ±11.9 kg) and
diabetic (71.4 ± 10.0 kg) subjects. Mean duration of diabetes
was 18 ± 9 years. Of the diabetic subjects, 17 had been treated
with insulin alone and 2 had been treated with diet and an oral
hypoglycaemic agent (Glyburide). None of the diabetic or con-
trol subjects was treated with any nonnolipidaemic medication.
Two diabetic subjects had retinopathy, 1 had angina pectoris
and 3 had hypertension. Blood was collected from each diabetic
subject and the paired control subject on the same day. These
studies were approved by the Committee on the Ethics of
Research in Human Experimentation at McMaster University.
Blood collection and preparation of erythrocyte
membranes
Blood (100 ml) was collected into a plastic syringe from a
forearm vein through an 18 gauge needle. Fourteen millilitres
of this blood were added to EDTA-containing vacutainer tubes
(Becton Dickinson, Missisauga, Ontario, Canada) for deter-
mination of HbAlc and glucose concentration of the plasma.
The remaining blood was anticoagulated with acid-citrate-dex-
trose solution (1 ACD + 6 blood, vol/vol) and used for prep-
aration of erythrocyte membranes. Red blood cells washed four
times with phosphate-buffered saune pH 7.4 were subjected to
moderate haemolysis in Tris-HCl/EDTANa2 buffer pH 7.0 ac-
cording to Marchesi & Palade (14). The isolated erythrocyte
membranes were resuspended in ice-cold phosphate-buffered
saline with phenylmethylsulphonyl fluoride, sodium azide and
EDTANa2. The protein content in erythrocyte membrane sus-
pensions was measured according to the modified method of
Lowry et al. (15). The membrane suspensions were subsequently
used for determination of membrane fluidity, cholesterol, phos-
pholipid, lipid peroxidation and non-enzymatic glycation of
membrane protein. The samples from diabetic and control
subjects were obtained, stored and analysed at the same time
and under the same conditions.
Isolation of low-density lipoproteins and high-den-
sity lipoproteins from plasma
In order to inhibit protease and lipase activities, plasma was
supplemented with 100 ml/1 of a solution containing phenyl-
methylsulphonyl fluoride (2 mmol/1), EDTANa2 (1 mmol/1), so-
dium azide (2 mmol/1). High density lipoproteins were separated
from low density lipoproteins by the precipitation of the latter
using a combination of sodium phosphotungstate and magne-
sium chloride (16), after prior separation of very low density
lipoproteins according to Schriewer et al. (17). Low density
lipoproteins and high density lipoproteins were purified ac-
cording to Mills et al. (16) and extensively dialysed against
phosphate-buffered saline with phenylmethylsulphonyl fluor-
ide/EDTANa2/NaN3 pH 7.2 at 4°C. Ten microlitres of ß-
hydroxytoluene in methanol (0.1 mol/1) were added per 1 ml of
lipoprotein solutions to protect samples from spontaneous per-
oxidation, and the samples were stored at —70 °C until assayed.
Fluidity measurements
Erythrocyte membrane fluidity was determined by measuring
fluorescence polarization (18) with the hydrophobic probe 1,6-
diphenyl-l,3,5-hexatriene (Molecular Probes, Eugene, OR,
USA; 0.5 mmol/1 in tetrahydrofuran). l,6-Diphenyl-l,3,5-hex-
atriene was diluted 1:100 in phosphate buffered saline, pH 7.4,
and vigorously mixed immediately before use. One volume of
this diluted l,6-diphenyl-l,3,5-hexatriene dispersion was added
to 1 vol of the erythrocyte membrane suspension containing
0.2 g/1 protein, and the mixture was incubated at 37 °C for 35
min. The final protein concentration was 0.1 g/1.
Steady-state fluorescence polarization was measured at 37 °C
with a Perkin-Elmer spectrofluorometer equippped with polar-
izers in the excitation and emission beams. The excitation and
emission wavelengths were 360 and 430 nm, respectively. Flu-
orescence polarization was determined using a standard for-
mula from emission intensities that were polarized parallel and
perpendicular to the direction of the polarized excitation (18).
The grating transmission factor of Chen & Bowman (19) was
used to correct for the depolarization effect of grating mono-
chromators (20). A fluorescence intensity value for a non-
labelled blank was subtracted as a correction for scattered light.
Fluorescence polarization values mainly reflect lipid structural
order, and lipid fluidity has been defined as the reciprocal of
the lipid structural order parameter (21).
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Measurement of cholesterol and phospholipids
Samples of the erythrocyte membrane suspensions containing
100 — 200 μ§ protein were subjected to lipid extraction using a
two-step extraction procedure with neutral solvent (chloro-
form : methanol, 1 + 2 , vol/vol) and acidic solvent (chloro-
form : methanol: HC1: water, 3 +4 + 0.5 + 0.1, vol/vol) (22).
The lipid extracts were dried under nitrogen and lipid residues
were re-dissolved in chloroform (1 ml). The cholesterol content
of lipid extracts of erythrocyte membranes was determined by
the cholesterol oxidase fluorometric assay (23), and phosphorus
was measured using ammonium molybdate and ascorbic acid
after mineralization with magnesium nitrate (24).
Measurement of glycat ion
The extent of glycation was determined as described earlier
(25). Aliquots of erythrocyte membranes or isolated lipopro-
teins containing 100 μg or 2mg protein, respectively, were
treated with equal volumes of 24 mmol/1 sodium borohydride-
[3H] (New England Nuclear, Mississauga, Ontario, Canada; 3.7
TBq/mol =100 mCi/mmol) and incubated at 37 °C for 2h.
After incubation, 30 g/1 bovine serum albumin was added to
each sample and the protein precipitated with 100 g/1 trichlo-
roacetic acid. The pellet was dissolved in 1 mol/1 NaOH and
reprecipitated with trichloroacetic acid. This procedure was
repeated 4—5 times until no further radioactivity could be
detected in the supernatant. Radioactivity was measured in the
final pellet redissolved in 1 mol/1 NaOH. Results were expressed
in nmol glucose assuming that 1 mol of glucose moiety adduct
is reduced by 1 mol of sodium borohydride-[3H].
Determinat ion of HbA l c and plasma glucose concen
trat ions
HbAic was determined in whole blood using a glycoaffmity
column (26) (the normal range of HbA!c is 4.5%-7.5%).
Plasma glucose was measured by the glucose oxidase method
with an Ektachem (Eastman-Kodak, Rochester, NY, USA) (27).
Measurement of l ipoperoxidat ion products
The products of lipid peroxidation in erythrocyte membranes
and in plasma lipoproteins were determined according to the
method of Wong et al. (28) with modifications. In principle, the
adduct of malondialdehyde with 2-thiobarbituric acid was sep-
arated from interfering chromogens on the HPLC column and
lipoperoxide concentrations were computed by reference to a
calibration curve prepared by assaying tetraethoxypropane. Be-
fore addition of thiobarbituric acid reagent the incubation
mixture was supplemented with -hydroxytoluene and the sol-
ubilizing agent, polyoxyethylene ether W-l (29) (Sigma Chem-
ical Co.), at the final concentrations of 3 mmol/1 and 1 g/1,
respectively. The amounts of lipoperoxides were expressed in
nmol of thiobarbituric acid reacting substance.
Analysis of data
Means ± SD are given. Paired t tests (2-tailed) were used to
determine the significance of differences. The normal distribu-
tion of data was confirmed using the Shapiro- Wilk's test (30).
A combined test for correlation coefficients was performed to
assess the relationships among the quantities investigated (31).
Results
The mean plasma glucose and HbAic were signifi-
cantly greater in diabetic patients than in control
subjects (2.12 ± 0.96 g/1 vs 0.84 ±0.16 g/1,
p < 0.001, and 12.5% ± 3.0% vs 5.8% ± 0.5%,
p < 0.001, respectively).
The mean steady-state fluorescence polarization value
of l,6-diphenyl-l,3,5-hexatriene in isolated erythro-
cyte membranes from diabetic subjects (0.186
± 0.008, n = 14) was significantly greater than that
for control subjects (0.173 ± 0.006, n = 14,
p < 0.001). The lipid contents of erythrocyte mem-
branes and of low-density lipoproteins and high-den-
sity lipoproteins are shown in table 1. The amount of
cholesterol and the cholesterol to phospholipid molar
ratio were significantly higher in isolated erythrocyte
membranes from diabetic subjects compared with
control subjects, but the phospholipid contents were
similar. In plasma low-density lipoproteins from di-
Tab. 1. Cholesterol and phospholipid contents of erythrocyte membranes and of plasma low-density lipoproteins and high-density













































Values are means + SD for 14 subjects in each group.
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abetic subjects, the concentration of cholesterol was
signficiantly higher (p < 0.025), and that of phospho-
lipid significantly lower (p < 0.025) than the corre-
sponding values for control subjects. In the plasma
high density lipoproteins, the cholesterol content was
not significantly different between groups, whereas
the amount of phospholipids was significantly lower
(p < 0.035) in diabetic subjects compared with con-
trol subjects. As a result of these differences in low
density lipoproteins and high density lipoproteins, the
cholesterol to phospholipid molar ratios were signif-
icantly higher in low density lipoproteins (p < 0.001)
and high density lipoproteins (p < 0.02) from diabetic
subjects compared with control subjects.
The amounts of non-enzymatically attached glucose
were significantly increased, both in erythrocyte mem-
branes (p < 0.001) and in plasma low-density lipo-
proteins (p < 0.001) and high-density lipoproteins
(p < 0.015) from diabetic subjects compared with
control subjects (tab. 2); the most significant differ-
ences occurred in erythrocyte membranes.
The levels of thiobarbituric acid reacting substances,
which are the hallmark of lipid peroxidation, were
Tab. 2. The extent of non-enzymatic glycation of proteins in erythrocyte membranes and in plasma low density lipoproteins and
high density lipoproteins from diabetic and control subjects.
Erythrocyte membranes (nmol glucose/mg protein)
LDL (nmol glucose/mg protein)















Values are means ± SD for 13 —14 subjects in each group.
Tab. 3. Lipoperoxide adducts in erythrocyte membranes and plasma low density lipoproteins and high density lipoproteins from


















Values are means ± SD for 11 subjects in each group.
Tab. 4. Correlation coefficients among the quantities examined in diabetic and control subjects.
Quantity
Erythrocyte membrane fluorescence polarization:
vs non-enzymatic glycation of erythrocyte membrane proteins
vs lipid peroxidation in erythrocyte membranes
vs cholesterol content in erythrocyte membranes
vs cholesterol/phospholipid (molar ratio) in LDL
vs cholesterol/phospholipid (molar ratio) in HDL
Non-enzymatic glycation of LDL:
vs lipid peroxidation in LDL
vs phospholipid content in LDL
vs cholesterol/phospholipid (molar ratio) in LDL
Erythrocyte cholesterol content:
vs cholesterol content in LDL
vs non-enzymatic glycation of HDL
Lipid peroxidation in LDL:
vs lipid peroxidation in erythrocyte membranes































Correlation coefficients are determined from 11 — 14 diabetic and 11 — 14 control subjects.
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increased in erythrocyte membranes and plasma li-
poproteins in diabetics subjects; the most highly sig-
nificant increase was observed in low-density lipopro-
teins (p < 0.01) (tab. 3).
The degrees of correlation between the various quan-
tities examined were determined for diabetic and con-
trol subjects (tab. 4). Fluorescence polarization values
in erythrocyte membranes significantly correlated
with the extent of non-enzymatic glycation, lipid per-
oxidation and the cholesterol content in these mem-
branes and also with the cholesterol to phospholipid
molar ratios in plasma low density lipoproteins and
high-density lipoproteins. In low density lipoproteins
the extent of non-enzymatic glycation significantly
correlated with peroxidation and the cholesterol to
phospholipid molar ratio and inversely correlated
with the phospholipid content. The cholesterol con-
tent of erythrocyte membranes significantly correlated
with the cholesterol content in low density lipopro-
teins and the extent of non-enzymatic glycation in
high density lipoproteins. Lipid peroxidation in low
density lipoproteins significantly correlated with lipid
peroxidation in erythrocyte membranes and with the
cholesterol content in low density lipoproteins. Other
correlations were not statistically significant.
Discussion
The results from the present study show that, com-
pared with erythrocyte membranes from controls,
erythrocyte membranes from diabetic subjects display
reduced membrane lipid fluidity, together with the
increase in membrane protein glycation, lipid perox-
idation, and the cholesterol to phospholipid molar
ratio. Furthermore, low density lipoproteins and high
density lipoproteins from diabetic subjects were more
extensively glycated, had a higher cholesterol to phos-
pholipid molar ratio, and contained greater amounts
of lipid peroxidation products than those from control
subjects. The extent of non-enzymatic glycation cor-
related with the extent of lipid peroxidation and the
cholesterol to phospholipid molar ratio in low density
lipoproteins from diabetic and control subjects, but
this correlation was not evident in high density lipo-
proteins or erythrocyte membranes. The values for
membrane lipid fluidity in erythrocytes from diabetic
and control subjects inversely correlated with the cho-
lesterol to phospholipid molar ratios in low density
lipoproteins and high density lipoproteins.
In our recent study, conducted within the same pop-
ulation of patients, we also found a significant inverse
correlation between membrane lipid fluidity and the
extent of non-enzymatic glycation of membrane pro-
teins in platelets from diabetic and control subjects,
although the cholesterol to phospholipid molar ratio
did not differ between platelets from diabetic and
control subjects (13). It seems reasonably certain,
therefore, to conclude that red blood cells are not
unique with respect to the rigidization of the mem-
brane lipid bilayer due to the increased membrane
protein glycation in the diabetic state. In platelets,
non-enzymatic glycation of membrane proteins also
results in the rigidification of the lipid bilayer.
Non-enzymatic glycation of low density lipoproteins
has been reported to alter the binding of low density
lipoproteins to platelets and to various other cell types
(32, 33). In some diabetics the level of glycation may
be sufficient to interfere with the normal metabolism
of low density lipoproteins (25). The extent of the
glycation of low density lipoproteins in diabetic ju-
veniles has been previously reported to correlate with
lipid composition of low density lipoproteins and the
cholesterol to phospholipid molar ratio in erythrocyte
membranes. These changes seemed to invoke the al-
terations in membrane lipid bilayer dynamics in eryth-
rocytes from diabetic subjects (12). Thus, non-enzy-
matic glycation of erythrocyte membrane proteins
seems to be of major importance in the impairment
of red blood cell functions; additionally it appears to
be involved in the augmentation of the rate of post-
synthetic modifications of plasma low density lipo-
proteins. Increased glycation of low density lipopro-
teins, either in vitro or in material isolated from
diabetic subjects, may lead to impaired uptake by the
classic low density lipoprotein receptor and the in-
creased uptake by human monocyte-derived macro-
phages (for reviews see (11, 34)). The former effect
may increase circulating low-density lipoprotein con-
centrations, whereas the latter effect may contribute
to foam cell formation, a precursor in the develop-
ment of atherosclerosis (9 — 11). Furthermore, a po-
sitive correlation between the degree of non-enzymatic
glycation of low density lipoproteins and the enhance-
ment of platelet aggregation has been demonstrated,
and numerous data suggest that glycated low density
lipoproteins may contribute to the hyperaggregability
of platelets in diabetics (32).
In the present study, we found significantly increased
cholesterol to phospholipid molar ratios in plasma
low density lipoproteins and high density lipoproteins
and in erythrocyte membranes from diabetic subjects,
and these changes were inversely related to the mem-
brane lipid fluidity of erythrocytes. Our present study
demonstrates that erythrocyte membranes, as well as
plasma low density lipoproteins and high density li-
poproteins from diabetic subjects, contain increased
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 9
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levels of thiobarbituric acid reacting substances com-
pared with control subjects. These changes were as-
sociated with a reduced membrane fluidity of eryth-
rocytes from diabetic subjects compared with control
subjects, which has been taken as evidence that lipid
peroxidation may be essentially involved in the mod-
ification process (35, 36). The concept is supported
by the significant inverse correlation found among
erythrocyte membrane fluidity and the extent of lipid
peroxidation in erythrocyte membranes and plasma
low density lipoproteins and high density lipoproteins.
This relation does not appear to have been examined
previously, but the reduced erythrocyte membrane
fluidity in the diabetic state is consistent with our
earlier reports, in which we showed a reduced mem-
brane fluidity in isolated erythrocyte membranes from
diabetic adults and juveniles, and the alterations were
found to relate both to the membrane lipid compo-
sition (37, 38) and to the extent of membrane protein
glycation (12, 39).
It has been shown that native and oxidatively modi-
fied lipoproteins differ importantly in their effects on
cells. The oxidized low density lipoproteins and high
density lipoproteins are more reactive than the native
ones, and they are thought to promote the vascular
events which are characteristic of atherogenesis (2,
11). Our results show that the increased lipid perox-
idation of erythrocyte membranes, low density lipo-
proteins and high density lipoproteins occurred in all
but 1, 2, and 3 diabetic subjects, respectively. With
respect to this finding our results do not agree com-
pletely with the results of the studies published hith-
erto. There is no direct evidence that lipid peroxida-
tion is increased in uncomplicated human diabetes
(40 — 42). With the exception of one report by Collier
et al. (43), the evidence suggests that peroxidation of
circulating plasma lipoproteins may not be related to
diabetes itself, but rather to the underlying diabetic
complications.
The positive correlation between the extent of glyca-
tion and thiobarbituric acid reacting substances level
is not obscure, since the process of non-enzymatic
glycation has been postulated to augment free radical
formation. This phenomenon may be of particular
importance in diabetic patients, where the sources of
free oxygen radicals are augmented by the increased
glycation of proteins, so that natural defences may be
overwhelmed (35, 36).
The formation of reactive aldehydes is known to
impair the physical properties and the flexibility of
red blood cell membranes (44). This seems to be the
case in the present study, as we found a very signifi-
cant inverse correlation between erythrocyte mem-
brane fluidity and the extent of erythrocyte membrane
lipid peroxidation.
The above reported observations suggest the potential
importance of glycated and oxidized low density li-
poproteins in the pathogenesis of atherosclerosis and
adds a new dimension to the relationship between
plasma lipoproteins and blood cell membranes in
diabetes, as well as implying a potential role of altered
lipoproteins in the pathogenesis of atherosclerosis.
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